Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?
Article in Frontiers in Pharmacology (April 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Targeting reprogrammed metabolism as a therapeutic approach for respiratory diseases
Article in Biochemical Pharmacology (March 2024)
The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy
Article in International Journal of Molecular Sciences (January 2024)